AzTrials
AzTrials

Oral Lichen PlanusHypnOLPNCT06697574

Hypnotherapy for Oral Lichen Planus. Patients with Clinically and Histologically Confirmed Oral Lichen Planus Would Be Randomized for Hypnotherapy Vs Psychoeducation About the Pyschoneuroimmune System. Follow Up Would Be Done At 2, 6, 12 Weeks After.

A study testing Hypnosis aimed at stress reduction and health of the oral mucosa and Psychoeducation in people with Oral Lichen Planus, run by Tel-Aviv Sourasky Medical Center at 1 site in Israel.

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record
Search all trials

Trial summary

60 patients with clinically and histologically confirmed Oral Lichen Planus, which are are typically followed up at our oral mucosal disease clinic with a standing diagnosis for at least 1 year would be randomized. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Oral Lichen Planus
What is being tested?
Hypnosis aimed at stress reduction and health of the oral mucosa and Psychoeducation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteIsrael
Study dates
29 Nov 2024to 29 Nov 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Histopathologically and clinically confirmed diagnosis of OLP.
  • At least 1 year since diagnosis.
  • Above 18 years of age.
  • Fluent in Hebrew or English (for the purpose of hypnosis).
  • Lesions that are consistent with OLP are clinically visible in oral cavity.

Who cannot join

  • Under aged.
  • Previous negative experience with hypnosis.
  • Psychiatric diagnosis of schizophrenia, personality disorder, severe depression, or history of psychosis.
  • Substantial cognitive decline.
  • Low hypnotisability.
  • Previous oral squamous cell carcinoma.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Israel1 site
  • Oral Medicine Unit, Tel Aviv Sourasky Medical Center

    Tel Aviv

Other trials in Israel

About this study

Official title: HypnOLP Trial Hypnotherapy for Oral Lichen Planus - a Single Blind Randomized Controlled Trial

60 patients with clinically and histologically confirmed Oral Lichen Planus, which are are typically followed up at our oral mucosal disease clinic with a standing diagnosis for at least 1 year would be randomized.

30 would undergo a session of psychoeducation and hyponotherapy and 30 would undergo psychoeducation alone. This would be done by the PI who is an oral medicine specialist and licensed for medical hypnosis.

Read more

Patients would be instructed to practice self hypnosis and would be followed up by their original oral medicine specialists who would be blinded to the intervention the had recieved - follow up would be done at 2, 6, and 12 week intervals.

Patients would be asked to fill 3 standardized questionnaires (translated to Hebrew and verified): PHQ-9, OHIP-14, ERQ . The clinical appearance of their lichen planus would be documented using a standardized semi-quantitive method as described by Piboonniyom et al, OOOO 2005

Read the detailed description

Background:

Lichen planus (LP) is an immune-mediated skin and mucous membrane disease that mainly affects middle-aged adults of both sexes with a slight tendency to women. The precise prevalence of LP is unknown, but it is estimated that the oral form (OLP) alone is expressed in about 1-2% of the population. OLP is a chronic disease and it is considered by the World Health Organization (WHO) as a pre-malignant condition. OLP presents in five clinical forms - reticular, plaque-like, erythematous/atrophic, erosive/ulcerative and bullous. The reticular form is the most common and is characterized by white papules and/or white mesh-like stripes called Wickham's striae, typically bilaterally and symmetrically distributed. The most affected site is the posterior buccal mucosa followed by the tongue, gingiva and labial mucosa.2 Usually, this condition is asymptomatic even if it is diffuse, but the erythematous, erosive and ulcerative forms might cause a painful burning sensation. In 1978 the WHO published diagnostic criteria for OLP based on clinical and histopathological characteristics and in 2003 van der Meij and van der Waal modified these criteria, which are accepted till this day.

Despite a vast number of studies, the etiology of OLP remains unknown. It is believed that OLP is a result of a local cell-mediated immune response, involving antigen-presenting cells and inflammatory infiltrate predominantly of T lymphocytes, but its precipitating factors have not been determined. Some conditions have been associated with OLP, including among others, genetic predisposition, specific microorganisms, several systemic health conditions, and emotional disorders. The latter have been thoroughly investigated and some studies have showed that OLP patients, especially those with the erythematous/erosive forms, have higher state of anxiety and depression than non-OLP individuals. It has been suggested that psychological factors can alter the functionality of the immune system, leading to the development of autoimmune diseases. To date, no study has conclusively demonstrated a cause-and-effect relationship and more investigations about the possible correlation of anxiety and emotions with the severity of OLP are needed.

Hypnosis is a natural human phenomenon and every human tends to have trance like events several times a day. Techniques for induction and deepening of the hypnotic trance can be utilized in order to maintain this state and access aspects of psyche and physiology that are not readily accessible in the ordinary waking state.

Ample literature is available on the use of hypnosis for treatment of medical conditions that are exacerbated by emotions such as autoimmune and autoinflammatory conditions. That being said there are only anecdotal reports of hypnotherapy being used for Lichen Planus of the skin and non for OLP.

Study design:

Patients with a histologically confirmed diagnosis of OLP for at least 1 year prior to participation and examined by Dr. Zlotogorski (AZ) or Dr. Whitefield (SW) would be offered to participate and would give signed consent.

Willing patients' presentation and behavior of OLP would be documented in a Clinical Research File (CRF) and clinically photographed. CRF would include frequency of need for topical/systemic steroids, retinoids, calcineurin inhibitors and a semiquantitive scoring system for monitoring oral lichenoid lesions (from Piboonniyom et al, OOOO 2005).

Questionnaires would be filled out.

All Patients would be given Hebrew versions standardized and validated questionnaires:

Emotion Regulation Questionnaire (ERQ), Patient Health Questionnaire (PHQ-9), Oral Health Impact Profile (OHIP-14).

At this point patients would be referred to Dr. Wasserman (GW) who is an oral medicine specialist and licensed to practice medical hypnosis as well as for research related to hypnosis by the hypnosis advisory committee to the ministry of health.

GW would conduct a test of hypnotisability using a pendulum and "magnetic fingers".

Patients who rank with low hypnotisability would be added to the control group.

Patients who rank well would be randomized into 2 groups:

  1. Psychoeducation group
  2. Psychoeducation and hypnosis group Randomization would be done by flipping a coin.

GW would administer a brief presentation of psychoeducation and the relevance of the psycho-neuro-immuno-endocrine system to OLP. Patients randomized for hypnosis would also receive an explanation about hypnosis. This is to establish rapport between GW and each patient. All patients would be instructed not to mention the contents of the session with GW to AZ or to SW.

For patients selected for hypnosis, a short interview would be conducted about themselves including hobbies, favorite practices and places, fears or dislikes, daily stressors and triggers, effect of OLP on their lives - this is to tailor metaphors and suggestions for each participant and to strengthen rapport.

Hypnosis would include:

  • Induction.
  • Hypnotic relaxation and escalating deepening of hypnotic trance.
  • Suggestions for healing and wellness of the oral mucosa and for balanced and optimal performance of the immune system, tailoring metaphors and images based on interview with patients.

"…the interior of the mouth is soft, healthy pink, intact and whole. It functions optimally as it should - enabling joyful eating and tasting, speaking with ease for any needed expression, any function of the mouth that needs to be used can be done so easily.

The immune system is very wise - it knows perfectly how to function in a balanced and harmonious way. Its wisdom enables it to act if the body needs defense and to standby and rest if it does not".

  • Ego strengthening.
  • Anchoring - using a predetermined mark selected by the patient.
  • Dehypnotisation.

After dehypnotisation patients would be guided through rapid trance induction by themselves using the anchor created while in trance.

In case of an abreaction during trance, patients would be excluded from the trial and referred to a psychologist.

At the end of the session patients would be instructed to practice self-hypnosis at least once a day and set a reminder on their phone. Patients selected for hypnosis would receive a weekly phone call to "nudge" the daily practice and also to record that number of times they practiced. The session would be documented under an "Oral Medicine - Research" admission and under "Research - confidential" on the hospital's electronic medical record platform.

Two weeks, 6 weeks, and 3 months after the session with GW, patients would be clinically reassessed by AZ or SW. They would receive a phone call or a text message as reminder not to mention the contents of their session with GW in order to secure the blinding.

On a day of follow up, questionnaires would be filled out, and AZ or SW would conduct a thorough clinical examination, enter data into the CRF and conduct photographic documentation.

As control 30 age matched OLP patients who meet the inclusion criteria but were not offered to participate or even told of the study would be analyzed retrospectively according to the medical record - all patients in the Oral Mucosal clinic would be documented using the same semiquantitive scoring system and NRS.

Data collected from these patients would include demographic information as well as their semiquantitive score which is always recorded for OLP patients. Data would be accessed from the "Chameleon" platform.

The data will be retrospectively collected and anonymously stored using a connecting list between the research code and the participants' details. Each participant will be given a number and the data will be typed into an electronic spreadsheet after all the identifying details have been deleted.

The connecting list will be kept in a locked closet of the PI, or in a password-protected computer at the hospital. The list will be destroyed once the data processing is complete. A note regarding that will be made at the report regarding the end of the research.

The separation of the identifying data will be made only by the PI or sub-PI, who is from the hospital's staff, with authorization to access medical files.

The file will not be sent by a non-encrypted e-mail and will be taken out of the hospital without signing a contract with the R\&D division.

The data will be stored in an anonymous file for a period of 7 years after the termination of the study. The file will be password-protedcted on the departmental server.

Data analysis Data will be analyzed using SPSS 28 (IBM). T-test would be used for continuous variables, ANOVA test would be used to test variability between groups, Chi square for nominal variables and correlation tests between groups.

Statistical significance is defined as p<0.05.

Being tested
Hypnosis aimed at stress reduction and health of the oral mucosa, Psychoeducation
Keywords
Oral Lichen Planus, Hypnosis
Medical subject headings
Lichen Planus, Oral

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Hypnosis aimed at stress reduction and health of the oral mucosaBehavioural

    • Induction.
    • Hypnotic relaxation and escalating deepening of hypnotic trance.
    • Suggestions for healing and wellness of the oral mucosa and for balanced and optimal performance of the immune system, tailoring metaphors and images based on interview with patients.

    "…the interior of the mouth is soft, healthy pink, intact and whole. It functions optimally as it should - enabling joyful eating and tasting, speaking with ease for any needed expression, any function of the mouth that needs to be used can be done so easily.

    The immune system is very wise - it knows perfectly how to function in a balanced and harmonious way. Its wisdom enables it to act if the body needs defense and to standby and rest if it does not".

    • Ego strengthening.
    • Anchoring - using a predetermined mark selected by the patient.
    • Dehypnotisation.
  • PsychoeducationBehavioural

    A short explanation about the psycho-neuro-immune system and its part in oral lichen planus

Study groups in NCT06697574
Study groupRoleWhat they receive
Psychoeducation and Hypnotherapy GroupExperimental30 Patients randomized to undergo psychoeducation and hypnotherapy
Receives: Behavioral: Hypnosis aimed at stress reduction and health of the oral mucosa; Behavioral: Psychoeducation
Psychoeducation GroupActive comparator30 Patients selected for psychoeducation with out hypnotherapy
Receives: Behavioral: Psychoeducation
Non intervention group - retrospectively analyzedNo intervention30 age matched patients from the oral mucosal clinic who's course and presentation of lichen planus would be retrospectively analyzed

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Improvement in clinical expression of Oral Lichen Planus

    The investigators expect to see an improvement in the clinical manifestation of oral lichen planus in the hypnotherapy group by assessing the score of the semiquantitive scale as described by Piboonniyom et al OOOO 2005

    Measured: 3 months

  2. Improvement in clinical expression of Oral Lichen Planus

    The investigators expect to see an improvement in pain or discomfort of oral lichen planus in the hypnotherapy group as stated on a 0-10 Numerical Rating Scale (NRS).

    Measured: 3 months

  3. Improvement in clinical expression of Oral Lichen Planus

    The investigators expect to see an improvement in the overall experience of living with oral lichen planus in the hypnotherapy group as measured buy the OHIP-14 questionnaire.

    Measured: 3 months

Secondary outcomes (2)
  1. Stress reduction and overall improvement in quality of life

    As assessed by questionnaires the investigators expect to see an improvement in stress and anxiety measured by the ERQ questionnaire.

    Measured: 3 months

  2. Stress reduction and overall improvement in quality of life

    As assessed by questionnaires the investigators expect to see an improvement in stress and anxiety measured by the PHQ-9 questionnaire.

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Nov 2024
  2. Study start29 Nov 2024 (estimated)
  3. Primary completion29 Nov 2026 (estimated)
  4. Study completion29 Nov 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
60 randomised patients as well as 30 retrospective
Masking
Single blind
Who is masked
Care provider
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06697574
Sponsor's protocol ID
TASMC-24-GW-0299-CTIL
Acronym
HypnOLP
Status last verified
Nov 2024
First submitted
11 Nov 2024
Last updated
20 Nov 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Patients IDs would be masked. Demographics, questionnaires, semiquantitive lichen planus assesment score would be recoreded - all in a spreadsheet. Would be available upon request to a specific journal reviewer or scientist.

Publications

  • Piboonniyom SO, Treister N, Pitiphat W, Woo SB. Scoring system for monitoring oral lichenoid lesions: a preliminary study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005 Jun;99(6):696-703. doi: 10.1016/j.tripleo.2004.07.013.

    PubMed 15897856
  • Shenefelt PD. Hypnosis in dermatology. Arch Dermatol. 2000 Mar;136(3):393-9. doi: 10.1001/archderm.136.3.393.

    PubMed 10724204
  • Day M, Clarke SA, Castillo-Eito L, Rowe R. Psychoeducation for Children with Chronic Conditions: A Systematic Review and Meta-analysis. J Pediatr Psychol. 2020 May 1;45(4):386-398. doi: 10.1093/jpepsy/jsaa015.

    PubMed 32219409
  • Marshall GD Jr, Agarwal SK, Lloyd C, Cohen L, Henninger EM, Morris GJ. Cytokine dysregulation associated with exam stress in healthy medical students. Brain Behav Immun. 1998 Dec;12(4):297-307. doi: 10.1006/brbi.1998.0537.

    PubMed 10080859
  • Zucoloto ML, Shibakura MEW, Pavanin JV, Garcia FT, da Silva Santos PS, Maciel AP, de Barros Gallo C, Souza NV, Innocentini LMAR, Humberto JSM, Motta ACF. Severity of oral lichen planus and oral lichenoid lesions is associated with anxiety. Clin Oral Investig. 2019 Dec;23(12):4441-4448. doi: 10.1007/s00784-019-02892-2. Epub 2019 Apr 15.

    PubMed 30989337
  • Vallejo MJ, Huerta G, Cerero R, Seoane JM. Anxiety and depression as risk factors for oral lichen planus. Dermatology. 2001;203(4):303-7. doi: 10.1159/000051777.

    PubMed 11752817
  • Alves MG, do Carmo Carvalho BF, Balducci I, Cabral LA, Nicodemo D, Almeida JD. Emotional assessment of patients with oral lichen planus. Int J Dermatol. 2015 Jan;54(1):29-32. doi: 10.1111/ijd.12052. Epub 2014 Sep 10.

    PubMed 25209436
  • Chaudhary S. Psychosocial stressors in oral lichen planus. Aust Dent J. 2004 Dec;49(4):192-5. doi: 10.1111/j.1834-7819.2004.tb00072.x.

    PubMed 15762340
  • Soto Araya M, Rojas Alcayaga G, Esguep A. Association between psychological disorders and the presence of Oral lichen planus, Burning mouth syndrome and Recurrent aphthous stomatitis. Med Oral. 2004 Jan-Feb;9(1):1-7. English, Spanish.

    PubMed 14704611
  • Rojo-Moreno JL, Bagan JV, Rojo-Moreno J, Donat JS, Milian MA, Jimenez Y. Psychologic factors and oral lichen planus. A psychometric evaluation of 100 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998 Dec;86(6):687-91. doi: 10.1016/s1079-2104(98)90205-0.

    PubMed 9868726
  • McCartan BE. Psychological factors associated with oral lichen planus. J Oral Pathol Med. 1995 Jul;24(6):273-5. doi: 10.1111/j.1600-0714.1995.tb01181.x.

    PubMed 7562664
  • Kramer IR, Lucas RB, Pindborg JJ, Sobin LH. Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol. 1978 Oct;46(4):518-39. No abstract available.

    PubMed 280847
  • Warnakulasuriya S, Kujan O, Aguirre-Urizar JM, Bagan JV, Gonzalez-Moles MA, Kerr AR, Lodi G, Mello FW, Monteiro L, Ogden GR, Sloan P, Johnson NW. Oral potentially malignant disorders: A consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer. Oral Dis. 2021 Nov;27(8):1862-1880. doi: 10.1111/odi.13704. Epub 2020 Nov 26.

    PubMed 33128420
  • van der Meij EH, van der Waal I. Lack of clinicopathologic correlation in the diagnosis of oral lichen planus based on the presently available diagnostic criteria and suggestions for modifications. J Oral Pathol Med. 2003 Oct;32(9):507-12. doi: 10.1034/j.1600-0714.2003.00125.x.

    PubMed 12969224

Questions about this trial

What is this clinical trial studying?

A study testing Hypnosis aimed at stress reduction and health of the oral mucosa and Psychoeducation in people with Oral Lichen Planus, run by Tel-Aviv Sourasky Medical Center at 1 site in Israel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: enrolling by invitation, as of the sponsor's last update on 20 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Improvement in clinical expression of Oral Lichen Planus (time frame: 3 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06697574, which also lists 14 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Nov 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in